Nitisinone not checked

Swedish Orphan Biovitrum

FollowEvery change as it happens, and a Monday email
Stage
in the US · approved in the EU
Next date
None yet
 
Trials
0 active
1 in total
Targets
—
None known yet

What this is

How it works
4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor FDA class
Main trialPhase 1
“The purpose of this study is to evaluate the bioequivalence between Orfadin 20 mg and 10 mg capsules in healthy volunteers.”In the company’s words, NCT01857362 on ClinicalTrials.gov

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 1Completed Jun 2013 Bioequivalence of Orfadin 20 mg Compared to Orfadin 10 mg Capsules.
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Nitisinone

Following is part of Solo: you see every change to Nitisinone the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in